Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Oxidation and Stereoselective Reduction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103319560A details a high-yield UDCA synthesis from CDCA using NBS oxidation and Luche reduction, offering cost reduction in API manufacturing and reliable pharmaceutical intermediates supply.